COMBINATION ANTRIRETROVIRAL REGIMENS AND TREATMENT-SWITCHING STRATEGIES IN CHILD

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。这项研究的目的是评估抗HIV药物的两种不同治疗组合，并确定从一种治疗组合切换到另一种治疗组合的两种方案中哪一种更好。这项研究将评估在为期四年的治疗中，这两个转换计划中的任何一个在益处上是否存在差异。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to evaluate two different treatment combinations of anti-HIV drugs, and to determine which of two plans for switching from one to the other treatment combination is better. The study will evaluate if there is a difference in benefit for either of the two switching plans in a four-year treatment.